Ligand Pharmaceuticals reported $13.72M in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Amgen AMGN:US $ 1884M 1420M
Anika Therapeutics ANIK:US $ 0.56M 5.97M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Arrowhead Research ARWR:US $ -63374000 33.45M
Baxter International BAX:US $ 450M 152M
Bristol Myers Squibb BMY:US $ 1546M 491M
Clovis Oncology CLVS:US $ -67.41M 0.96M
Dicerna Pharmaceuticals DRNA:US $ -17.07M 23.74M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Endo International Ordinary Shares ENDP:US $ -77.21M 61.71M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Gilead Sciences GILD:US $ 2592M 1070M
GlaxoSmithKline GSK:LN 1168M 227M
Glaxosmithkline GSK:US $ 1168M 227M
Harsco HSC:US $ 7.56M 5.82M
Immunogen IMGN:US $ -37.34M 6.6M
Insmed INSM:US $ -112714000 4.61M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Lannett LCI:US $ -22.34M 155.54M
Ligand Pharmaceuticals LGND:US $ 13.72M 17M
Macrogenics MGNX:US $ -52.89M 12.95M
Merk MRK:US $ 4567M 3022M
Pacira Pharmaceuticals PCRX:US $ 17.66M 1.42M
Pfizer PFE:US $ 8146M 2582M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Spectrum Pharmaceuticals SPPI:US $ -33.08M 17.05M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M
Veracyte VCYT:US $ -14.13M 5.09M